Lung Cancer Diagnostics Market Size, Industry Analysis
Report, Regional Outlook & Forecast,2017-2024: Global
Market Insights Inc.
Lung Cancer Diagnostics Market size should witness significant growth due to increased
prevalence of smoking and exposure to secondhand smoke, influencing the occurrence
rate of lung malignancies. Smoking is forestalled to be the major cause of approximately
85 per cent of cancer. The surging dominance of cancer is directly proportional to the
business growth, owing to the high demand for diagnosis and early disease screening.
Mounting technological advancements such as the development of specific biomarkers
facilitates the customized treatment approach of lung malignancies eventually driving
the lung cancer diagnostics market during the forecast period. The rising awareness
levels amongst the populace and the availability of government as well as private funds
for R&D of better tumor diagnostic tools further fuels the industry growth.
Evidences show that beta-carotene supplements and arsenic in drinking water
intensifies the risk of lung cancer, and accounted for 8.8 million deaths in 2015. An
estimated 14 million adults have been diagnosed with the disease worldwide, with its
prevalence expected to reach 21.7 million by 2030Increased exposure to radon,
asbestos, secondhand smoke, air pollution, or other factors cause lung cancer in
nonsmokers. Genetics also play a vital role for disease occurrence in non-smokers.
Workplace exposures to diesel exhaust, asbestos and other chemicals increases the
chance of cancer. As per WHO, lung cancer accounted for 1.69 million deaths worldwide
Increasing number of programs to enhance public awareness will create immense
growth opportunities. For instance, the Centers for Disease Control and Prevention
(CDC) introduced Tips from former smokers (Tips), a paid national tobacco education
campaign. The campaign profiles people surviving with long-term serious health
damage caused from smoking. The main objectives of the campaign are to encourage
smokers to quit and not to smoke around nonsmokers, building public awareness of the
immediate health issues caused by exposure to secondhand smoke and smoking.
Prohibitive cost associated with the treatment for lung cancer and limited
reimbursement policies in low and middle-income countries may hamper the lung
cancer diagnostics market growth.
1 | Page